MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 143 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q2 2016. The put-call ratio across all filers is 1.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $1,244,000 | -59.6% | 1,003,802 | +0.4% | 0.00% | -100.0% |
| Q1 2017 | $3,079,000 | -21.2% | 999,734 | +4.4% | 0.00% | -50.0% |
| Q4 2016 | $3,906,000 | -27.0% | 957,540 | +13.6% | 0.00% | -33.3% |
| Q3 2016 | $5,353,000 | +20.6% | 843,126 | +2.4% | 0.00% | +50.0% |
| Q2 2016 | $4,437,000 | -31.5% | 823,280 | +6.4% | 0.00% | -33.3% |
| Q1 2016 | $6,476,000 | +12.4% | 773,750 | +6.1% | 0.00% | 0.0% |
| Q4 2015 | $5,763,000 | +2.7% | 729,505 | +10.6% | 0.00% | 0.0% |
| Q3 2015 | $5,612,000 | -32.6% | 659,504 | -2.0% | 0.00% | -40.0% |
| Q2 2015 | $8,324,000 | +5.3% | 673,191 | +1.2% | 0.01% | 0.0% |
| Q1 2015 | $7,905,000 | +13.7% | 665,495 | +8.1% | 0.01% | +25.0% |
| Q4 2014 | $6,952,000 | +52.6% | 615,354 | +18.6% | 0.00% | +33.3% |
| Q3 2014 | $4,556,000 | +20.5% | 519,013 | +0.1% | 0.00% | +50.0% |
| Q2 2014 | $3,780,000 | +45.7% | 518,585 | +0.7% | 0.00% | 0.0% |
| Q1 2014 | $2,595,000 | +4.6% | 515,085 | +10.8% | 0.00% | 0.0% |
| Q4 2013 | $2,482,000 | +52.5% | 464,863 | +8.5% | 0.00% | +100.0% |
| Q3 2013 | $1,628,000 | +118.8% | 428,460 | +287.3% | 0.00% | 0.0% |
| Q2 2013 | $744,000 | – | 110,618 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|